Showing 2,421–2,440 of 17,937 drug recalls
Drug Recall
Terminated
Historical record Class II
Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30-count cartons (NDC 0113-0847-39), and b) 45-count cartons (NDC 0113-0847-95), Distributed by: Perrigo, Allegan, MI 49010. by L. Perrigo Company
Reason
Failed Impurities/Degradation Specifications Recall initiated
February 9, 2023 Reported by FDA
July 19, 2023 Distribution
Nationwide within the USA
View recall →
Drug Recall
Terminated
Historical record Class II
Fexofenadine Hydrochloride Tablets, 180 mg, 100-count cartons, Distributed by: Perrigo, Allegan, MI 49010. NDC 45802-847-78 by L. Perrigo Company
Reason
Failed Impurities/Degradation Specifications Recall initiated
February 9, 2023 Reported by FDA
July 19, 2023 Distribution
Nationwide within the USA
View recall →
Drug Recall
Terminated
Historical record Class II
allergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-count cartons (NDC 79481-0847-0), b)30-count cartons (NDC 79481-0847-1), and c) 45-count cartons (NDC 79481-0847-2), Distributed by: MEIJER DISTRIBUTION, INC., GRAND RAPIDS, MI 49544. by L. Perrigo Company
Reason
Failed Impurities/Degradation Specifications Recall initiated
February 9, 2023 Reported by FDA
July 19, 2023 Distribution
Nationwide within the USA
View recall →
Drug Recall
Terminated
Historical record Class II
Allergy ALLER-FEX, Fexofenadine Hydrochloride Tablets, 180 mg, 180-count cartons, Packaged by: Perrigo, 515 Eastern Ave., Allegan, MI 49010 USA. NDC 63981-847-48 by L. Perrigo Company
Reason
Failed Impurities/Degradation Specifications Recall initiated
February 9, 2023 Reported by FDA
July 19, 2023 Distribution
Nationwide within the USA
View recall →
Drug Recall
Terminated
Historical record Class II
aller-ease, Fexofenadine Hydrochloride Tablets, 180 mg, 30-count cartons, Packaged For: Your Military Exchanges, By: Perrigo Company, Allegan, MI USA 49010. NDC 55301-847-39 by L. Perrigo Company
Reason
Failed Impurities/Degradation Specifications Recall initiated
February 9, 2023 Reported by FDA
July 19, 2023 Distribution
Nationwide within the USA
View recall →
Drug Recall
Terminated
Historical record Class II
Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, 30-count cartons, Distributed By: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895. NDC 69842-0914-39 by L. Perrigo Company
Reason
Failed Impurities/Degradation Specifications Recall initiated
February 9, 2023 Reported by FDA
July 19, 2023 Distribution
Nationwide within the USA
View recall →
Drug Recall
Terminated
Historical record Class II
Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, 15-count cartons, Distributed By: Adusa Distribution, LLC, Salisbury, NC 28147. NDC 72476-847-22 by L. Perrigo Company
Reason
Failed Impurities/Degradation Specifications Recall initiated
February 9, 2023 Reported by FDA
July 19, 2023 Distribution
Nationwide within the USA
View recall →
Drug Recall
Terminated
Historical record Class II
Non-Drowsy Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, 150-count cartons, Distributed By: BJ's Wholesale Club, 25 Research Drive, Westborough, MA 01581. NDC 68391-847-47 by L. Perrigo Company
Reason
Failed Impurities/Degradation Specifications Recall initiated
February 9, 2023 Reported by FDA
July 19, 2023 Distribution
Nationwide within the USA
View recall →
Drug Recall
Terminated
Historical record Class II
Allergy, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30-count cartons (NDC 72288-847-39), and b)150-count cartons (NDC 72288-847-47 and 72288-847-37), Distributed By: Amazon.com Services LLC., 410 Terry Avenue N., Seattle, WA 98109. by L. Perrigo Company
Reason
Failed Impurities/Degradation Specifications Recall initiated
February 9, 2023 Reported by FDA
July 19, 2023 Distribution
Nationwide within the USA
View recall →
Drug Recall
Terminated
Historical record Class III
Amlodipine Besylate Tablets, USP 10 mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 U.S, Manufactured by: Lupin Limited, Aurangabad 431 210 India, NDC 68180-721-03 by Lupin Pharmaceuticals Inc.
Reason
Subpotent Drug: Out-of-Specification test results observed in assay test at 21-month long term stability study. Recall initiated
June 27, 2023 Reported by FDA
July 19, 2023 Distribution
Product was distributed directly to three distributors in TN and NJ. Product may have been further distributed throughout the United States.
View recall →
Drug Recall
Ongoing
Historical record Class II
Dry Eye Relief Lubricant Eye Drops, (Glycerin 0.2%, Hypromellose 0.2 %, Polyethylene glycol 400 1%), 0.5 FL OZ (15mL) bottle, packaged in a) equate, DISTRIBUTED BY: Walmart Inc., Bentonville, AR 72716, 2-0.5 FL OZ (15 mL) Bottles, 1 FL OZ (30 mL) TOTAL, UPC 6 81131 36701 1, NDC 49035-280-02; b) DG health, DISTRIBUTED BY OLD EAST MAIN CO., 100 MISSION RIDGE, GOODLETTSVILLE, TN 37072, UPC 0 95072 02656 0; c) sunmark, Distributed By McKesson, 6555 State Highway 161, Irving, TX 75039, UPC 0 10939 62144 3, NDC 49348-037-29; d) TopCare health, DISTRIBUTED BY TOPCO ASSOCIATES LLC, ELK GROVE VILLAGE, IL 60007, UPC 0 36800 36100 3; e) HealthMart, Distributed by McKesson, 6555 State Highway 161, Irving, TX 75039, UPC 0 52569 13715 4; f) exchange select Artificial Tears, Manufactured for your Military Exchanges by: KC Pharmaceuticals, Inc., Pomona, CA 91768, UPC 6 14299 05620 6; g) meijer, DIST. BY MEIJER DISTRIBUTION, INC., GRAND RAPIDS, MI 49544, UPC 7 13733 29692 2, NDC 41250-718-01; h) H.E.B, MADE WITH PRIDE AND CARE FOR H.E.B, SAN ANTONIO, TX 78204, UPC 0 41220 43741 2; i) GeriCare, Distributed by: Gericare Pharmaceuticals Corp., 1650 63rd St., Brooklyn, NY 11204, UPC 3 57896 18405 6, NDC 57896-181-05 by K.C. Pharmaceuticals, Inc
Reason
CGMP Deviations: good manufacturing deficiencies related to a lack of documentation of the fill line. Recall initiated
June 13, 2023 Reported by FDA
July 19, 2023 Distribution
Nationwide in the USA
View recall →
Drug Recall
Ongoing
Historical record Class II
Original Eye Drops; Redness Reliever; (Tetrahydrozoline HCl), 0.05%, 0.5 FL OZ (15mL); distributed by a) Original Formula Eye Drops, DG health, DISTRIBUTED BY OLD EAST MAIN CO, 100 MISSION RIDGE, GOODLETTSVILLE, TN 37072, UPC 0 95072 00556 5; b) Publix, DISTRIBUTED BY PUBLIX SUPER MARKETS, INC, 3300 PUBLIX CORPORATE PARKWAY, LAKELAND, FL 33811, UPC 0 41415 01076 5; c) sterile eye drops, Original Formula, sunmark, Distributed by McKesson, 6555 State Highway 161, Irving, TX 75039, UPC 0 10939 16733 0, NDC 49348-037-29; d) TopCare health, DISTRIBUTED BY TOPCO ASSOCIATES LLC, ELKGROVE VILLAGE, IL 60007, UPC 0 36800 03639 0; e) Eye Drops, Original Formula, GoodSense, Distributed By: Geiss, Destin & Dunn, Inc., Peachtree City, GA 30269, UPC 1 80410 00015 6, NDC 50804-141-01; f) sterile eye drops, Circle K, Product manufactured for: Lil' Drug Store Products, Inc., 9300 Earhart Lane SW, Cedar Rapids, IA 52404 Proudly distributed by Circle K Stores Inc., UPC 1 94283 65185 8; g) Sterile Eye Drops, Regular Formula, Lil Drug Store, Product manufactured for: Lil' Drug Store Products, Inc., 9300 Earhart Lane SW, Cedar Rapids, IA 52404; UPC 3 66715 68324 3; h) Tetrahydrozoline Ophthalmic Solution, Rugby, Distributed by: Rugby Laboratories, 17177 N Laurel Park Drive, Suite 233, Livonia, MI 48152, UPC 3 05361 21794 5, NDC 0536-1217-94, i) Leader, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO 43017, UPC 0 96295 13645 6, NDC 70000-0454-1; j) REDNESS RELIEF EYE DROPS, CAREone, Distributed by: FOODHOLD USA, LLC, LANDOVER, MD 20785; UPC 0 41520 86531 1, NDC 41520-431-05; k) Eye Drops, Original Formula, Good Neighbor Pharmacy, Distributed By AmerisourceBergen, 1300 Morris Drive, Chesterbrook, PA 19087, UPC 0 87701 14975 7, NDC 24385-075-05; l) Eye Drops, ORIGINAL FORMULA, Walgreens, DISTRIBUTED BY: WALGREEN CO., 200 WILMOT RD., DEERFIELD, IL 60015, UPC 3 11917 20076 7; m) CVS Health, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 36131 3; n) H-E-B, MADE WITH PRIDE & CARE FOR H-E-B, SAN ANTONIO, TX 78204, UPC 0 41220 43747 4; o) redness relief, Original Redness Reliever Eye Drops, meijer, DIST. BY MEIJER DISTRIBUTION INC., GRAND RAPIDS, MI 49544, UPC 0 41250 82916 4, NDC 41250-814-01; p) Eye Drops, ORIGINAL, Best Choice, PROUDLY DISTRIBUTED BY: VALU MERCHANDISERS, CO., 5000 KANSAS AVE, KANSAS CITY, KS 66106, UPC 0 70038 47011 3 by K.C. Pharmaceuticals, Inc
Reason
CGMP Deviations: good manufacturing deficiencies related to a lack of documentation of the fill line. Recall initiated
June 13, 2023 Reported by FDA
July 19, 2023 Distribution
Nationwide in the USA
View recall →
Drug Recall
Ongoing
Historical record Class III
PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured by VIVUS LLC, Campbell, CA 95008, UPC: N3 62541-401-10 5, NDC 62541-401-10, by Vivus, Inc.
Reason
Failed Stability Specifications Recall initiated
June 23, 2023 Reported by FDA
July 19, 2023 Distribution
Nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram- 603 110, Tamilnadu, India, NDC 64380-933-08 by Strides Pharma Inc.
Reason
Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet. Recall initiated
June 26, 2023 Reported by FDA
July 12, 2023 Distribution
Nationwide in the USA.
View recall →
Drug Recall
Ongoing
Historical record Class II
Tizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2), b)30-count bottles (NDC: 68788-7781-3), c) 60-count bottles, (NDC: 68788-7781-6), d) 90-count bottles (NDC: 68788-7781-9), e) 120-count bottles (NDC: 68788-7781-8), Rx only, Mfg: Dr. Reddy's Laboratories Limited. by Preferred Pharmaceuticals, Inc.
Reason
Failed Stability Specifications Recall initiated
June 26, 2023 Reported by FDA
July 12, 2023 Distribution
Nationwide within the United States
View recall →
Drug Recall
Terminated
Historical record Class II
Tizanidine Tablets, USP, 4 mg, 100 Tablets (10 tablets x 10 unit dose blister packs) per carton, Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 68084-645-01 (carton), barcode (01) 003 68084 645 11 2. by Amerisource Health Services LLC
Reason
Failed Dissolution Specifications: this repackaged product was recalled by the manufacturer, Dr. Reddy's Laboratories, Inc., due to out of specification results for dissolution. Recall initiated
June 23, 2023 Reported by FDA
July 12, 2023 Distribution
Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical record Class II
Amphotericin B Liposome for Injection, 50mg/vial, Rx only, Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti, Halol-389350, Gujarat, India, NDC 62756-0233-01 by SUN PHARMACEUTICAL INDUSTRIES INC
Reason
Subpotent drug Recall initiated
May 30, 2023 Reported by FDA
July 5, 2023 Distribution
USA nationwide
View recall →
Drug Recall
Terminated
Historical record Class II
StellaLife VEGA Oral Care Gel, 1 fl oz (30 ml) tubes, Peppermint, Distributed by: StellaLife, Inc., Aventura, FL NDC 69685-112-01 by Homeocare Laboratories, Inc.
Reason
cGMP deviations Recall initiated
June 5, 2023 Reported by FDA
July 5, 2023 Distribution
Product was distributed USA nationwide.
View recall →
Drug Recall
Terminated
Historical record Class II
StellaLife VEGA Oral Care Gel, 1 fl oz (30 ml) tubes, Distributed by: StellaLife, Inc., Aventura, FL NDC 69685-102-02 by Homeocare Laboratories, Inc.
Reason
cGMP deviations Recall initiated
June 5, 2023 Reported by FDA
July 5, 2023 Distribution
Product was distributed USA nationwide.
View recall →
Drug Recall
Terminated
Historical record Class II
StellaLife VEGA Oral Care Spray, 1 fl oz (30 ml) bottles, Distributed by: StellaLife, Inc., Aventura, FL NDC 69685-101-02 by Homeocare Laboratories, Inc.
Reason
cGMP deviations Recall initiated
June 5, 2023 Reported by FDA
July 5, 2023 Distribution
Product was distributed USA nationwide.
View recall →
Data last updated: September 10, 2026 ET
This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace
does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice --
always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take.
Read the full medical disclaimer .
